Dalgleish A - Search Results

1

Cryopreserved dendritic cells for intratumoral immunotherapy do not require re-culture prior to human vaccination.

John J, Dalgleish A, Melcher A, Pandha H. John J, et al. Among authors: dalgleish a. J Immunol Methods. 2005 Apr;299(1-2):37-46. doi: 10.1016/j.jim.2004.12.014. Epub 2005 Jan 28. J Immunol Methods. 2005. PMID: 15890354

2

Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study.

Pandha HS, John RJ, Hutchinson J, James N, Whelan M, Corbishley C, Dalgleish AG. Pandha HS, et al. BJU Int. 2004 Aug;94(3):412-8. doi: 10.1111/j.1464-410X.2004.04922.x. BJU Int. 2004. PMID: 15291878 Clinical Trial.

3

Successful live cell harvest from bisected sentinel lymph nodes research report.

Elliott B, Cook MG, John RJ, Powell BW, Pandha H, Dalgleish AG. Elliott B, et al. J Immunol Methods. 2004 Aug;291(1-2):71-8. doi: 10.1016/j.jim.2004.04.025. J Immunol Methods. 2004. PMID: 15345306

4

Cryopreservation of immature monocyte-derived dendritic cells results in enhanced cell maturation but reduced endocytic activity and efficiency of adenoviral transduction.

John J, Hutchinson J, Dalgleish A, Pandha H. John J, et al. Among authors: dalgleish a. J Immunol Methods. 2003 Jan 15;272(1-2):35-48. doi: 10.1016/s0022-1759(02)00430-1. J Immunol Methods. 2003. PMID: 12505710

5

Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity.

Todryk SM, Eaton J, Birchall L, Greenhalgh R, Soars D, Dalgleish AG, Melcher AA, Pandha HS. Todryk SM, et al. Among authors: dalgleish ag. Cancer Immunol Immunother. 2004 Apr;53(4):323-30. doi: 10.1007/s00262-003-0452-1. Epub 2003 Nov 28. Cancer Immunol Immunother. 2004. PMID: 14648067 Free PMC article.

6

Detection of T cell cytokine production as a tool for monitoring immunotherapy.

John J, Pandha H, Dalgleish AG. John J, et al. Among authors: dalgleish ag. Dis Markers. 2000;16(1-2):71-5. doi: 10.1155/2000/163267. Dis Markers. 2000. PMID: 11360831 Free PMC article. Review. No abstract available.

7

Advances in prostate cancer immunotherapy.

Havranek EG, Whelan MA, Greenhalgh R, Dalgleish AG, Pandha H. Havranek EG, et al. Among authors: dalgleish ag. Surg Oncol. 2002 Jun;11(1-2):35-45. doi: 10.1016/s0960-7404(02)00012-9. Surg Oncol. 2002. PMID: 12031866 Review.

8

Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.

Kovalcsik E, John J, Turner M, Birchall L, Sage D, Whittle R, Dalgleish A, Pandha H. Kovalcsik E, et al. Among authors: dalgleish a. Melanoma Res. 2004 Dec;14(6):463-71. doi: 10.1097/00008390-200412000-00005. Melanoma Res. 2004. PMID: 15577316

9

Tumor antigens as surrogate markers and targets for therapy and vaccines.

Dalgleish A, Pandha H. Dalgleish A, et al. Adv Cancer Res. 2007;96:175-90. doi: 10.1016/S0065-230X(06)96009-6. Adv Cancer Res. 2007. PMID: 17161680 Review.

10

Oncological applications of gene therapy.

Pandha HS, Martin LA, Rigg AS, Ross P, Dalgleish AG. Pandha HS, et al. Among authors: dalgleish ag. Curr Opin Investig Drugs. 2000 Sep;1(1):122-34. Curr Opin Investig Drugs. 2000. PMID: 11249588 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

427 results

Search Page